Reversing liver damage in alcohol-related hepatitis
Part of Digestive system, Mental health clinical trials.
This trial studies whether people with alcohol-related hepatitis can see their liver function improve. It looks at patients whose diagnosis is supported by blood tests and imaging, and excludes those with liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical suspicion of alcohol-related hepatitis.
- Your bilirubin level is 50 mmol/L or higher.
- Ultrasound or other imaging supports the diagnosis.
- You must be able to give written consent.
- The study treatment must start within 2 months of diagnosis.
- You do not have liver cancer (hepatocellular carcinoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an optimized treatment plan can improve remission in people with liver cirrhosis caused by alcohol. It aims to help patients achieve better health outcomes.
This trial tests a program to help people recently diagnosed with alcohol-related liver disease cut back on drinking. If you qualify, you may get support to improve your liver health.
This trial tests a combination of treatments for people with severe alcohol-related liver disease (alcoholic hepatitis) that has not responded to standard care. The goal is to improve liver function and help you stop drinking.
This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.
This study looks at how immune cells in the blood respond in people with alcoholic hepatitis and in people who drink heavily (with no known liver disease). It may help researchers understand why liver inflammation happens after heavy alcohol use.
This study tests a new drug called MRG-001 to see if it helps people with alcoholic hepatitis. The trial is looking for patients who have severe alcoholic hepatitis (with jaundice starting in the last 8 weeks) and have been drinking heavily for at least 6 months.
Hear when a new Alcoholic Hepatitis (AH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.